Arbutus Biopharma Corp (NASDAQ: ABUS) kicked off on Monday, up 3.25% from the previous trading day, before settling in for the closing price of $3.69.
On Monday, Arbutus Biopharma Corp (NASDAQ: ABUS) was 4.46% up from the session before settling in for the closing price of $3.59. A 52-week range
Arbutus Biopharma Corp (NASDAQ: ABUS) on Monday, soared 4.49% from the previous trading day, before settling in for the closing price of $3.12. Within the
Arbutus Biopharma Corp (NASDAQ: ABUS) on Tuesday, soared 0.32% from the previous trading day, before settling in for the closing price of $3.12. Within the
Arbutus Biopharma Corp (NASDAQ: ABUS) on Friday, soared 3.39% from the previous trading day, before settling in for the closing price of $2.95. Within the
On Friday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -4.19% down from the session before settling in for the closing price of $3.34. A 52-week range
A new trading day began on Tuesday, with Arbutus Biopharma Corp (NASDAQ: ABUS) stock price down -2.34% from the previous day of trading, before settling
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
